德國Evotec www.evotec.com
藥物發(fā)現(xiàn)和開發(fā)的制藥和生物技術公司的合作伙伴 
Evotec是在發(fā)現(xiàn)和創(chuàng)新的小分子藥物開發(fā)的領導者。本公司已建立了一個強大的平臺，適用于所有的目標治療領域，并在中樞神經系統(tǒng)（CNS）的地方，是建立合作的候選藥物管道有關的疾病領域的專門知識。通過研究合作與Evotec提供最高質量的研究成果，其合作伙伴在專利項目的制藥和生物技術行業(yè)。

The premier drug discovery and development partner for pharmaceutical and biotechnology companies
Evotec is a leader in the discovery and development of novel small molecule drugs. The Company has established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System (CNS) related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects Evotec is providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries.

Proprietary CNS pipeline
Evotec's proprietary projects specialize in finding new treatments for diseases of the Central Nervous System (CNS). The focus of research is on major CNS related conditions, including sleep disorders, Alzheimer's disease, pain management and smoking cessation - fast growing therapeutic areas with large unmet medical needs. Evotec has a diverse product pipeline with candidates at various stages of development. The Company's most advanced product candidate, which has recently completed Phase II clinical trials with excellent results, is EVT 201, a partial positive allosteric modulator of the GABAA receptor complex for the treatment of insomnia. Through selective in-licensing and the use of its platform for internal discovery efforts, Evotec intends to further develop and expand its preclinical and clinical CNS pipeline for partnering.

Research collaborations
In research collaborations, Evotec has established itself as the partner of choice for pharmaceutical and biotechnology companies worldwide by providing high quality, innovative and integrated solutions from drug target to clinic through an unmatched range of capabilities, including assay development, high-throughput and high-content screening, fragment-based drug discovery and medicinal chemistry. Applying its proven expertise in close collaboration with customers, Evotec is committed to delivering the highest levels of research and can quote outstanding references with the names of the world's leading pharmaceutical and biotechnology companies appearing among its many partners. To fully exploit the potential of its capabilities, Evotec increasingly complements its traditional fee-for-service business with higher value, results-driven projects in core areas by sharing in the customer's risk and success through significant milestone payments and royalties.

Evotec is a high performance organization that manages for innovation and efficiency across all areas. We aim to recruit, train, motivate and retain premier talent and to support our partners through the partnering of preclinical and clinical assets as well as results-orientated, highly collaborative relationships, creating innovative solutions using outstanding capabilities and thought leadership.